N
Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:matthew stone sr200+selma blair2000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+sean combs10000+boeing 747500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Early trial data support" (30 stories)

Top Headline Story

Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results
Lead StoryThe Sick Timesgeneral
Sep 15

Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQY1pkWkNJcEJFRFNPTDVVdnlycUZIUWV5REx0RnExR3BoQ2k2UzZ2M1dVRkNNX0VYUjNfWERlR2gxb1hiVGlTWlkzR2k0RTc5RGZWdVhQanlJRm1MRnFvWFVTdXgyaXA1NXE2b1JkZlJ5ZmliaTBNbUZvenhOdGM2cDE1X1RLb05HczU4TXMzUmtZVUl4Uk9mTWdfMHA3R1Z1VUJDVXVKakpyY3cyX2xFWjFZMTJESkZlNVpBZzhNRVRpY05UZVlaT25kNTE5UQ?oc=5" target="_blank">Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results</a>  <font color="#6f6f6f">The Sick Times</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+19m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
2000+39m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

Filter stories
5000+49m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+49m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories

Search Results for "Early trial data support"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data
Fierce Pharmatech

Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNb3EzNS1OQzFuTjlaLTZKcUk5Wnh5Wjl1djdTbENtZTZDdWVLNC12RDJWSVFPSmtBdFdUbUhRc3VUdFJ1d0RRbDIxejlvalFleHdHWWhoUFdWN3NMLWhtZFFuWnAwRy01R0FQVHVoU0thRkJZT0pGeGhHY3pPSTE2NERnTXJQY3ZFWm92eVMxenhhS2xDaklRbXdJay10Q0FQYkFfV2J0QmctUlVsVUxDNF9sdlFUemJf?oc=5" target="_blank">Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
Under-the-skin Briumvi supported by early MS clinical trial data
Multiple Sclerosis News Todayworld

Under-the-skin Briumvi supported by early MS clinical trial data

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPR3d0UGhOU2Q3SkZxRnBNOEQwMW5jeEVyYUlfRTc0ZjFpRHM1Y1JRZGhIU1pkU05SUGRSY01ZMTZWYXhTQ0txd1dwdmpqdzFhSnhQMnNwUzlUU1VyakJHelVRODd5bmQtZU82Y1pCSFZlWXkyS3pYQm9obEFmbGtIV3pnN3c1SVRSY2hGeWRpLVAzZ3ZEN1NWS0NQMjVJM196Zk9mMDRONWVtZkw5dWVhQU9Renpsc1VwZ0c4?oc=5" target="_blank">Under-the-skin Briumvi supported by early MS clinical trial data</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
Oral prosetin proves safe in early trial, paving way for Phase 2
ALS News Todaygeneral

Oral prosetin proves safe in early trial, paving way for Phase 2

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQNzVBWTUtelhJWHQxZVh1b3NSbWlvTXc0eURoRU9CaXJpY2dVU1VOeFRmRDZCMEZsV2xqbUFMdXZ5WHpoMG5nRGFfRGJVTmNmU0VDWUM1dktaZHFxM3VicUEzbWQ4WUEteGNKRXdiUDZCclQxb0FNcXhWSmpvOGtKRlZXRVc0SFpWR2F4Z2FrT3o?oc=5" target="_blank">Oral prosetin proves safe in early trial, paving way for Phase 2</a>  <font color="#6f6f6f">ALS News Today</font>

Read Full StoryMore like this
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
GRAILtech

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxNcHFmYzBIaUxmQ0NzSkJLMkl4VnhlLTBPdkpjN3dMRkNzUzJ6aUlCUU9LZFJPc3g0QzdPbDdEeThnV0tJSWNmcVpFa3pJLVlDMm1yaU5qanB0VVZDdGhkQjE4a1JIWjhaRjRhbFV1dHJPMXJocUpaSnp6aUhUTlBjUG1sQmk4clJxMDJTWUdrd0EyWHl2V1IwT19kSlRBWmhyQnBtSFBNazBpbVYzYzZLRk1RcDhnOWJZN0ZKMWJ0S0JVV3I2VWZBRlhyQ1pDM0dDek5lQ3dYOVMwendVdDRNZEl4QU9wRkVYV20wVXZnNWtSLUgtbWR4Y3ZadnFwSk9yRzJ4a0ZMOA?oc=5" target="_blank">GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting</a>  <font color="#6f6f6f">GRAIL</font>

Read Full StoryMore like this
First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data
Genetic Engineering and Biotechnology Newsgeneral

First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQkF5eGVZUW9SbzZnLUswOExXdk1lYnl2UFJ1Nl9jcnhjcC1PcFpQSnRXdU5xUmZfcXBVRERkRTM4MkcyenMzNXFUUFo0MEZLbjBiX0ZNbVlGbmVmclgxV0xELW1BeWw1bGtZQ0NZemhOQjVwYk9mcXloRWhUVjlEQXRBcDRWNmI5UkVIa2daUDFSNGpLVWtnWFR6T1p4SUI5cE1ybXZobWs1VTVETDVMUWVLa2N3b1R0bVNwZEpoOUdNQQ?oc=5" target="_blank">First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Read Full StoryMore like this
Mixed Topline Results for Anti-Tau Agent in Phase 2 Trial of Early AD
Medscapegeneral

Mixed Topline Results for Anti-Tau Agent in Phase 2 Trial of Early AD

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxObnM4cVdFanRFeFZFWndDV0liNXAxZ1RKV3NGRzBCckh3TERqclpaZmozdUtiSkNnTnJBb2E2WC11NVdTQVdUbHhvY09DVDdmMTctN0FYb2dtWmhPTjNHQUFyMlVRWUd1VmFEeGtvOVNsM1B3cFNubWFfcXRnWnNKMlRtcjF1S2FnUFo3WmtQVEpGNWNveUVUVXZZZVdDOU5SQThGYVQ3WldxYmlkM1E?oc=5" target="_blank">Mixed Topline Results for Anti-Tau Agent in Phase 2 Trial of Early AD</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Briumvi outperforms Aubagio when given as first MS therapy, per trial data
Multiple Sclerosis News Todaygeneral

Briumvi outperforms Aubagio when given as first MS therapy, per trial data

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPLXR5OUtIR3dDUFhHM3Uwa0RURFljSnRmTDk5eDRqVnVXejZZd1pHN0FvcmJnc19yQ3M3eHVmVnJvdXRpWmRXRUlaTGtiMzhaR1JMaGZTaUJuVmlNMy0yZjZudF9iYmFUcFhxMGR5RHQ5MHJ6bUlCT0xGSzZqNXpNcVZSemxfY0pubmdoa3lRcE5pam9XVjROWDJlX1VjWnZPOXkwcEZ3NnM0S0hQNE9XUnA2VXNLMWhwek90MHhoRjBsdw?oc=5" target="_blank">Briumvi outperforms Aubagio when given as first MS therapy, per trial data</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
FMD - First results from NHS-Galleri trial presented at international conference
Queen Mary University of Londongeneral

FMD - First results from NHS-Galleri trial presented at international conference

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxQLXQweWY1S29IOUt0THgzSDhyYWd3MERQV043enFNZFdxRU03eGhEdHVxM3ZraUNVT2ZSeEdPRXJkZ2llZlZCQnQtR3BaZW1heGJKZTZHM0JBUWdIenVUaVRxZnRMekYwMDJQMnBnV29ORmtiUnlVLWRST25pS0VWTmtjNmtWMEw2bW1QRUF0WmMyT3R2Qmticm9VSmNlMF9GU0JZZHcyUHJaOFp1LVNzeDV3bU1YbFRGajQ2ZFEwOFV3anNNZzZtMlJuOWk2cFFGZzNHUjBqZncySDJqbmlvWVh3Z0x1SzA?oc=5" target="_blank">FMD - First results from NHS-Galleri trial presented at international conference</a>  <font color="#6f6f6f">Queen Mary University of London</font>

Read Full StoryMore like this
Early trial data support RNA therapies for two muscular dystrophy types
Muscular Dystrophy Newsgeneral

Early trial data support RNA therapies for two muscular dystrophy types

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNalVJQlFFQ1luWTlnNDdETGdJdDJoUGFoOGlJa0NxVktjVk9tLTlTRjFhSjFUVDVkRGdISjdXeEp0RE8tSE5tb19DaVY5RHduSmIxVEF1cGFxTmF1M0lNQURHV2F6X0RPTnZuaGtiX21yb2l3SjFGaENmSHoxLXBibE5XU0VVUXlHMlh5M0RjTjlaQ3J2T1ZLNGhQOHQtWHZlbzNr?oc=5" target="_blank">Early trial data support RNA therapies for two muscular dystrophy types</a>  <font color="#6f6f6f">Muscular Dystrophy News</font>

Read Full StoryMore like this
New trial data show early biological signals for Parkinson’s therapy
Parkinson's News Todaygeneral

New trial data show early biological signals for Parkinson’s therapy

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQaW9FREdtTlNRY2VkdTJCUUZQNkVDVHllU2JMbm5sdUdpZkFNc0ZKSTFOLTBvSnhZblJ6OGF6NFNXd0ZWUmhYSjRaZU1MYnRKMjB2YzF1NlFPMUxBRllyWmZEaTRjSUx4UFhjTlBKYU1LaE9udXpPRThCbmZiUi1OMGxfeUZNRFRPM2xnOFZPQWJPWVBucGFKOGpycVREZw?oc=5" target="_blank">New trial data show early biological signals for Parkinson’s therapy</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
Ocugen, Inc.world

Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNVldBMENYeks3RnhvUnpZQ0hvWndFY3FxUmhSWm9CSjJsa0l3YmFlZ0loelJKdlpKbjB0MzhEVURWb0RMaEFaSzNWejNLanJOOGdOZFRubnF2b2NTUzFCTzJjRzktTWg3WWQxcy12Y1Z1QjdqQS1GYzIwMk5ZM3kwd2prdXlFaS1vTE5pQU4weVhMdjRtMHhDU205S3VXb3A3VXJlWXRiM2NTWUJ5eWpmWUhfYTJlVHlLSmhYSzdB?oc=5" target="_blank">Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa</a>  <font color="#6f6f6f">Ocugen, Inc.</font>

Read Full StoryMore like this
Data Bolster Support for Imlunestrant (Inluriyo) in ER-Positive, HER2-Negative Advanced Breast Cancer
Oncology News Centralworld

Data Bolster Support for Imlunestrant (Inluriyo) in ER-Positive, HER2-Negative Advanced Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxPcmxHS3J6dkFpQnl0Xzh6cy1tSTlJWGtQMVc4YVc2LUhFMjltVkZQMXNEalFTN1pzcTk2dUx5WmVhTmt1aG9fNkZmYVZPZU0ySTNDZXctM204OURIbG9fQlFNWHB0aWdVX2hsVmxxU0NiSHYtMXF3aFVLeDlOMmpVeS1KNExFQlcwR3RmVWpBdGJTdXVuVW9qRE0yQ3VXM1A3Tlg4ejI4SXlIMVVYNzFTSU5jeGFtSWNiZVZVbmRSRVdvNVZVWDY5QWxZYnBET1dUMzQ4RmdiVzJaT0N1QkdKeFNlSTFfVGgwRTJUVg?oc=5" target="_blank">Data Bolster Support for Imlunestrant (Inluriyo) in ER-Positive, HER2-Negative Advanced Breast Cancer</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Antibody therapy to clear CF lung infections fares well in early trial
Cystic Fibrosis News Todayworld

Antibody therapy to clear CF lung infections fares well in early trial

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQclZLaXdWNVV6bVZPUFRjcDZ1X1BNUTZDaGt3TzFqOG5QSW1tN1gwYmZPV0xETzZDbllSc1JzM1d6U05hRFg2bTZGTTAyU29vYmJkRlBqLWMxTWRTemZQd2VmUmZCS1hYR3lHaFZpMmJib3c1X1AwX2F3MVMwU3Y5aFgwZzdScHdldzJfUDdVUWItTGEzTHBQeFdsRzVubVZvV2hsUDhuTm83dw?oc=5" target="_blank">Antibody therapy to clear CF lung infections fares well in early trial</a>  <font color="#6f6f6f">Cystic Fibrosis News Today</font>

Read Full StoryMore like this
TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer
OncLivegeneral

TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOR2QtVGZ0aTFEOVljV0NEZjJnZGl3VWtRYUI1SFNtaHZleVlnazRDWlQ5dlFJZkpDb0RwckhWWktaRjlBYnNRRmZYRWFQRGZ0UXQ3N01FLWUtZ2llbkJReS1yY2piZU1ienRUUU1scTM3UnR2OVVXa2hZcm96c056Xzk2ZXhNUUZhR1ZTWE0yZ3lkbDFoenJqX082ZEpHcWl5b2VHcGJ5WUp1WjNvU2xtX1ZPM29qVXllMzU2QVFPSQ?oc=5" target="_blank">TROPION-Breast02 Data Support Dato-DXd as New First-Line SOC in Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
The Use of Real-World Data and Evidence in Clinical Trials
Applied Clinical Trials Onlineworld

The Use of Real-World Data and Evidence in Clinical Trials

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPS1ZCX21XdFB0RVR6enRoNWItTzlLUm43SnU1Zk1SOHFZaVBZTVlKUF9DNjNGRTZJNkNyOWQ0UHM2UkdKMzFCRlhZQTYtb2FoUWMtMTdXdERTY29hajR6S0NwV0pyVVdPM3hUOTA0bG9NOUtJcDlya0pVQ0lQZWdyM0Z1Qml1UzF6Umo4Q1VWWVBVdlhtTTh6Zg?oc=5" target="_blank">The Use of Real-World Data and Evidence in Clinical Trials</a>  <font color="#6f6f6f">Applied Clinical Trials Online</font>

Read Full StoryMore like this
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing
Memorial Sloan Kettering Cancer Centergeneral

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxNZlJKVldlMFZXaGJ2NXdDMHdiWEhwd1VvZDhkN01NaE1WZlZ1VzJ0NmVES3FweWhYR2ZkaXhTQVIxQUVZWS1Td3JKRzVqRUdnQUUyUzNycUs0NUlrZTFaTWFZa0ZEZk04VzJPakV4MG5VZW15d2lFYWtWVF9JOXNyNm9WS0hvaDd4UDNTcjJ3SGRsNEZBLWdlTmVvdjNXdmRVRUt4VGwyamZ6ZERjbXFGRUQ2QQ?oc=5" target="_blank">Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
Trial data support 1-dose antibiotic treatment for early syphilis
CIDRAPgeneral

Trial data support 1-dose antibiotic treatment for early syphilis

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPaFZDaThiVlA4NHdjeU9rcW0xa01QaTN1XzFHRE5VS09zMUZmSi1iSVJzZjY2NFBFeG9MY21KaU5aMjF3WFUyZ2EtOTdPb2ltU204Mld1X1JBaGo0MGgycHdkOVVPUmh6VUFKaUJkMmVMbFVkVERHMWxiNVFEM1RyZUJhM1N0QUhGT3FHZlVOR2xKakM1bVJ2TFdoaW1yUlU0SzhIdnlZS1pyWTNDaWJyMk9KTlM?oc=5" target="_blank">Trial data support 1-dose antibiotic treatment for early syphilis</a>  <font color="#6f6f6f">CIDRAP</font>

Read Full StoryMore like this
Early trial data suggest GT-02287 may ease Parkinson’s symptoms
Parkinson's News Todaygeneral

Early trial data suggest GT-02287 may ease Parkinson’s symptoms

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOTDhxTXdma1ZHNjlod2liYWNXOFplbEVGVjR6elJmbWdZRXNTY1ViU1pwR1o0NDF2TjdQS1I3WDBPc1JTU3h3UHdsNGJDbVdSR2tPMmhDVFpQalNSOXN0X3hBNV94NEhJWGkwUVhYbDBEc1VrLTFoc0MxV2hzbHUwSTlLWHpyRlhiVXRUZ0JzT2ktYTRJM2JPdmw0Zw?oc=5" target="_blank">Early trial data suggest GT-02287 may ease Parkinson’s symptoms</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
New funding to support Serina’s SER-252 trial in advanced Parkinson’s
Parkinson's News Todayworld

New funding to support Serina’s SER-252 trial in advanced Parkinson’s

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPN0VabHhqUTVXVkpPck1VM0FOQ1VGU2pNMUFTSXBnTzBDZXJOa01vcnZYVHM1Z2gzQXN6SktDUURUZ1JKUmlWSU80REZFVE1sd3dHeS03am8tVjRmQktCVU1Lc2JlVVcza0w4QVgzTC0tQjd2XzNpZnJUOGFOc2U1Umx3aVo3cW1LNjVCMkh3NG1vdGoyMlE?oc=5" target="_blank">New funding to support Serina’s SER-252 trial in advanced Parkinson’s</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Biogenworld

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWUtmTGFVOXljU2pNYVNYeEFKVHNWeUlueGZWMTFCNUJsN0dEVmtBQzRpWUNOLVRtSFgtaWJqYktRXy16ZW13eTk1eEhHLTZSUTlnbXA2UkVUNFA0Z2hzQlFKMjdDUEdWcnk0d19JNTJUUlZ1b2NIdncxQllqUHg2dnVjSU53dTR0cXoxUGl1MlN0ZnNaVTMxVmx6ZmdfalRVZ0drZkdkOWZkTmxKX2VDcDZDNWdIUUlrOVg5eDliaHRxdW8?oc=5" target="_blank">Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)</a>  <font color="#6f6f6f">Biogen</font>

Read Full StoryMore like this
Full Phase 3 Trial Data Support Lecanemab for Early Alzheimer’s |...
Alzheimer's News Todaygeneral

Full Phase 3 Trial Data Support Lecanemab for Early Alzheimer’s |...

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQdnN2cFNxZ1QxMU5zRWNlTEQtbTZMaG16Q0lXTndFb2FnSlVLUGdtd0EtSFlGcjIwVW9mWTJCalZwZ3pQcktVaGUyM3RUOF9XdC15T0MwTzJOTjdkRG5hNGFqRTBHWmVMWU9zNVpBekJGSG45UUhja0ZKVVFVWDBpMUQ0cl9xV01seU9Sb1RmTXo4R0NWbEdlOW9DQWY?oc=5" target="_blank">Full Phase 3 Trial Data Support Lecanemab for Early Alzheimer’s |...</a>  <font color="#6f6f6f">Alzheimer's News Today</font>

Read Full StoryMore like this
The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial
HDBuzzworld

The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcnV0Rk9KNjJHdy1YVG55RXJpRU9LX1l4YW1faGIyLTR2d3FyOTg4ZUNNdHRpSWlSRHB2Si1uUjJJbHNINlFnWDhoSGZXZWMtcmVrWHEyelNhWUg4U0w4U3RtLWNEZEwtSFNRVDRpOG4tNVVyOTBnVmpTLVdDR3dYZHg5TUVXWUItSk1zSmxtV1h1MkVRVlRvcUt1TFo3YWI4MkFjUEZ6LWNldw?oc=5" target="_blank">The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial</a>  <font color="#6f6f6f">HDBuzz</font>

Read Full StoryMore like this
AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...
Muscular Dystrophy Newsgeneral

AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPakJBeFA2X3Z2WUtJR2t5RXZ0ZjVCcGVsX2RNX1IyZ1V3bzUzMlRaSXV1YXZVQzVmNFBiOGJHem85NlBxNmFuNFI0STM4SEhGLWVab1A4NlBqOVpEb3k4VXFLc0pwVkMxUWFKcHlZXzVxa0doSzV1WS1YOHJGbUF1ZkI5R1VnN3NyNHV4ZkpXVTJoc1U?oc=5" target="_blank">AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...</a>  <font color="#6f6f6f">Muscular Dystrophy News</font>

Read Full StoryMore like this
First-in-Class Bispecific Posts Strong Data in Phase 2 NSCLC Trial
Oncology News Centralgeneral

First-in-Class Bispecific Posts Strong Data in Phase 2 NSCLC Trial

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNSm9idXNkOXgwVElsMWRQQWhWSEppOVZNdnVMVi1WQ3FIbGtsbkdXMHdSZEVDVlJDbTBQN1J3WDlIQWFZMURLUmVJdkpwNVFveWNVeGp0d01xbWJpMGFubEthQXpRTXlNaDlITGpQSzZoRGdmWDVlQmFhTFc4VVJmeHBWTjRRZHlqNWZXOWFHbnVfSWZkY2Y1dW8ydHExT0xQSmhndXR0WkhRZnJs?oc=5" target="_blank">First-in-Class Bispecific Posts Strong Data in Phase 2 NSCLC Trial</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
Eli Lillygeneral

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxON3NVckJMRldHbWRFSGlabUtDcEdycEd2MkxmUGlSc2dfcWhkWlQ3aDZ3QUlBeS11akFzMU40QjE1VzdwZE1hU2RoTWlxdVlYdmd0b2x4Yk4tcXR6SWNRZnFqa1dlU2haOFp5NkJWRjFSQXVVdmJYUzlMS3FtT3RDSFU4cmtlSkhXLUZtQkMzQ2M1cXF1RzJjRXFDc1lfOWw3ZnRjblVlc0UzRVRzeV93NDV6dERqWDJMaEN5V1hOMXZheHc2?oc=5" target="_blank">Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial</a>  <font color="#6f6f6f">Eli Lilly</font>

Read Full StoryMore like this
TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip
TCTMD.comgeneral

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNY0kxMlpRSlY0OTl4bW41TDUtR3NOOVVPaGh4c0JQbF9Ia08zdnlDRUtNNy0xcGlpTDM3di1aR01WT1p6NGtja0dEZmZjbHQtd1hwM1RCZ0tWRXVIaWV0b3R2MEJGRXdZTVJ2aEQ2clZpOC1oQmY3a3BfZllRZ2lpTTd3UXkxQW1jSjA1bnpPeG0xS2c2S3AyOGdPSQ?oc=5" target="_blank">TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
Two Phase 3 Trials at ASCO GI Support New Frontline Colorectal Cancer Options
Oncology News Centralgeneral

Two Phase 3 Trials at ASCO GI Support New Frontline Colorectal Cancer Options

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOalN1Wmg5cWlweE83TkVDcmFxSGZqNFVkYkktcUF3SUxEcVdUZlBWemtSUFZKbU9fd3ZELUZCY3lTV3ZET2cwZ2huWHVWV09uRUJoclhLUFJROTROZGhMSnBKaEJNeWpIR3NyWms0SGNsSmhMSUR4bWNGdVhfakxmQVZSZk91R2JwSXBYaVd3a0l0WFNIMjF4NnF5d1lJdElFa2VxeHlIMDNqRUFUdHFuVlJUbXBuZlV4OUowTDhwblBqWjh0RWoyeThCbw?oc=5" target="_blank">Two Phase 3 Trials at ASCO GI Support New Frontline Colorectal Cancer Options</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial
Naturegeneral

Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yYXZ6RDlwcmgwcGl4LVZkQTVzbGhyVlh2Qy03Z2pIRWtEZ2FKQkFsN1dVcEx3c084ZFdtOGxCYUpPOFR5X3lCX1ZfQTlXZ2VKUHk4dFoyelYyaU1pM2pJ?oc=5" target="_blank">Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Phase 2 Trial Data Support AR1001 as Potential Alzheimer Disease Monotherapy
NeurologyLivegeneral

Phase 2 Trial Data Support AR1001 as Potential Alzheimer Disease Monotherapy

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNTzB0TDM2VUZzQTdhME5DLVhXYVkxVWpGNmF0NXpFWlVTRzk1WDFuY2IwbzBSQjJhOFZqbDlMZU9ndG1GZWUxZFdCZG5HVWV4ZGxZRDRHR1BkYlIzdmFfbmV0bUNtcER4cW42M1VONG03ellKbTBmQ0RiZE1CbkRKS19ka2xXa0ZJakducmhsYm03bHpJbWo3SGRYMEJnc3E5NkJQN2drUmk4c2tN?oc=5" target="_blank">Phase 2 Trial Data Support AR1001 as Potential Alzheimer Disease Monotherapy</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
"Early trial data support" — Live Google News Trends & Headlines